Are Pharma Stocks the Next Growth Story?
April 24 (Bloomberg) -- Bloomberg's Jonathan Ferro reports that low patent expirations may clear the obstacles to growth for pharma stocks. He speaks on Bloomberg Television's "Countdown." (Source: Bloomberg)
Most Recent Videos
Century Aluminum CEO Says Halting Subsidies to Spur Jobs
03:16 - Mike Bless, Century Aluminum's chief executive officer, discusses the Trump administration's investigation of aluminum imports. He speaks with Bloomberg's Julie Hyman and Scarlet Fu on "Bloomberg Markets." (Source: Bloomberg)